Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS …
Importance Continuous positive airway pressure (CPAP) and high-flow nasal oxygen
(HFNO) have been recommended for acute hypoxemic respiratory failure in patients with …
(HFNO) have been recommended for acute hypoxemic respiratory failure in patients with …
Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months
Purpose Clinical characteristics and management of COVID-19 patients have evolved
during the pandemic, potentially changing their outcomes. We analyzed the associations of …
during the pandemic, potentially changing their outcomes. We analyzed the associations of …
The role of noninvasive respiratory management in patients with severe COVID-19 pneumonia
E Akoumianaki, E Ischaki, K Karagiannis… - Journal of personalized …, 2021 - mdpi.com
Acute hypoxemic respiratory failure is the principal cause of hospitalization, invasive
mechanical ventilation and death in severe COVID-19 infection. Nearly half of intubated …
mechanical ventilation and death in severe COVID-19 infection. Nearly half of intubated …
[HTML][HTML] Non-invasive respiratory support paths in hospitalized patients with COVID-19: proposal of an algorithm
JC Winck, R Scala - Pulmonology, 2021 - Elsevier
Abstract COVID-19 related Acute Respiratory Failure, may be successfully treated with
Conventional Oxygen therapy, High Flow Nasal Cannula, Continuous Positive Airway …
Conventional Oxygen therapy, High Flow Nasal Cannula, Continuous Positive Airway …
An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
Background Both continuous positive airway pressure (CPAP) and high-flow nasal
oxygenation (HFNO) have been recommended for acute respiratory failure in COVID-19 …
oxygenation (HFNO) have been recommended for acute respiratory failure in COVID-19 …
[HTML][HTML] Non-invasive respiratory support strategies in COVID-19
E Gorman, B Connolly, K Couper… - The Lancet …, 2021 - ncbi.nlm.nih.gov
April 16, 2021 https://doi. org/10.1016/S2213-2600 (21) 00168-5 scaffold for intravascular
thrombus formation. It might also cause thrombotic microangiopathy in the microvasculature …
thrombus formation. It might also cause thrombotic microangiopathy in the microvasculature …
SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures
Background Continuous positive airways pressure (CPAP) and high-flow nasal oxygen
(HFNO) are considered 'aerosol-generating procedures' in the treatment of COVID-19 …
(HFNO) are considered 'aerosol-generating procedures' in the treatment of COVID-19 …
[HTML][HTML] Methylene blue for treatment of hospitalized COVID-19 patients: a randomized, controlled, open-label clinical trial, phase 2
D Hamidi-Alamdari, S Hafizi-Lotfabadi… - Revista de …, 2021 - scielo.org.mx
HAMIDI-ALAMDARI, Daryoush et al. Methylene Blue for Treatment of Hospitalized COVID-
19 Patients: A Randomized, Controlled, Open-Label Clinical Trial, Phase 2. Rev. invest …
19 Patients: A Randomized, Controlled, Open-Label Clinical Trial, Phase 2. Rev. invest …
COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol
SJ Marciniak, J Farrell, A Rostron… - European …, 2021 - Eur Respiratory Soc
Pneumothorax is an important complication of coronavirus disease 2019 (COVID-19)[1, 2].
Based on a series of 60 individuals, we previously estimated that 0.91% of people admitted …
Based on a series of 60 individuals, we previously estimated that 0.91% of people admitted …
Conventional oxygen therapy versus CPAP as a ceiling of care in ward-based patients with COVID-19: a multi-centre cohort evaluation.
Background Continuous positive airway pressure (CPAP) therapy is commonly used for
respiratory failure due to severe COVID-19 pneumonitis, including in patients deemed not …
respiratory failure due to severe COVID-19 pneumonitis, including in patients deemed not …